Together, these findings paint a complex but enlightening picture of SOX3’s multifaceted role in glioblastoma and glioma, offering valuable insights into its potential as a biomarker and therapeutic target in the fight against these diseases. The gene discussed is SOX3; the disease is central nervous system cancer.